① PRIMARY — ISPE Pharmaceutical Engineering Feature (durable, citable credibility asset; lower promotional risk pre-pilot). Action now: send the editor query to PEmag@ispe.org (request GAMP ERB pre-submission discussion). Full manuscript via ScholarOne (mc.manuscriptcentral.com/ispe-pe) only on editor invitation. Gates: Vimal go-ahead + Public Claim Register sign-off; original/unpublished; GREEN disclosure. Doc: Verixa_Publications/ISPE_PharmaEng_2026_Feature_Proposal_2026-06-20.md. ② SECONDARY — ECA 2nd Annex 22 / AI Conference (E-EU-01) · 7-8 Oct 2026 Copenhagen · pitch as a narrowed working session, not an overview. Gates (all must hold before sending): (a) ISPE query in + originality cleared; (b) content materially distinct from ISPE manuscript; (c) do NOT circulate ECA slides publicly before ISPE accepts; (d) confirm ECA still accepts 2026 external speakers. Doc: Verixa_Publications/ECA_Annex22_2026_Speaker_Proposal_2026-06-20.md. Open verification before publishing either: EU AI Act high-risk reasoning → confirm with EU regulatory counsel.
India + US + EU pharma conferences · conclaves · webinars · founder speaker / panel posture pre-W14 · booth/sponsor only post-Sep-01 Verified-Go-Live · owner: Vimal · prepared 2026-06-18 · enriched 2026-06-18 with verixa_event_research
53
Events tracked (IN·US·EU·GBL)
21
HIGH-ROI events
5
Urgent / time-sensitive
8
Webinar tracks
FY27
Booth/sponsor window
🚨 Urgent / time-sensitive — act this week
AIPM Symposium on AI in Pharmaceutical Medicine 2026 — DECISION 20 Jun 2026: NOT SUBMITTING.Poster abstract deadline Mon 30 Jun 2026; Oct 13-14 2026, UC Berkeley. Founder decision — weaker QA-buyer density / off primary ICP; effort redirected to the ISPE publication + ICP-dense events. (Entry E-US-G → DECLINED.)
ET Pharma Tech Conclave 2026 — Fri 24 Jul 2026, Hyderabad. 6 weeks out · India AI-in-pharma event · 200+ attendees · perfect ICP. Action: Droupathy emails ETPharma editorial/programme team this week for speaker/panel slot ("AI in GMP: from Schedule M readiness to Annex 22 validation evidence"). NO public CFP — outreach is the channel.
FDLI Annual Conference 2027 — CFP OPENS MON 17 AUG 2026. May 5-6 2027, Washington DC + virtual. ~7 weeks to prepare CFP submission ("FDA AI/ML guidance meets GxP validation"). Owner: Vimal + Droupathy first-draft.
KENX AI in GxP webinar series — NEXT WEBINAR Tue 12 Aug 2026. Online · directly names Annex 11/22 + AI governance + GxP validation. Action: Droupathy pitches co-webinar / guest-expert slot for one of Aug 12, Sep 9, Oct 14, or Nov 11.
BIO-Europe partneringONE® opens ~Aug 2026 for Nov 9-11 Cologne event. Vimal applies for BIO Member Company before partneringONE® opens.
RESI virtual partnering days 29-30 Jun 2026 — last 2 days of San Diego virtual partnering. Investor-side priority but tagged for awareness.
💡 Insights & Top-5 highest-leverage targets
#1 PDA/FDA Joint Regulatory Conference 2026 · Sept 14-16 Washington DC · direct FDA/PDA audience · CGMP + PQS + AI regulatory-oversight content · posture: private meetings + late narrow panel pitch · HIGH ROI.
#2 Veeva R&D and Quality Summit US 2026 · Oct 20-21 Boston · 2,500+ life-sciences QA/RA/IT attendees · highest QMS-buyer concentration in the US · posture: customer/partner-mediated intro + private meetings (NO booth · vendor competitor risk).
#3 ET Pharma Tech Conclave 2026 · Jul 24 Hyderabad · India AI-in-pharma · perfect founder speaker slot if pitched this week · Caplin / Solara-Synthix / Cohance / SMS all Hyderabad-area.
#4 iPHEX 2026 · Sep 7-9 New Delhi · India exporter / CDMO / API audience under Schedule M + USFDA + EU pressure · Pharmexcil-led · posture: private meetings via Pharmexcil network.
#5 FDLI Annual Conference 2027 · May 5-6 Washington DC + virtual · CFP opens Aug 17 2026 · best regulated-AI thought-leadership slot · "validated AI evidence for FDA-regulated pharma QMS."
Posture rule (locked from Marketing Plan §11 + Appendix I): Speaker / panel / poster / private breakfast ONLY through verified-go-live decision (Sep-01). NO booth sponsorship pre-Sep-01.
Dual-gate rule applies to event marketing content too: any session abstract making regulatory / AI / CSA / data-residency / audit-readiness claims passes through Public Claim Register before submission. CFP application itself is internal, not a public claim.
📅 Action plan timeline (from verixa_event_research · synced to Marketing Plan §16)